The “Kissing Disease” May Be Linked to a Much Bigger Health Risk Than Most People Realize

Mononucleosis has long been nicknamed the “kissing disease” because the Epstein-Barr virus behind most cases can spread through saliva, but scientists are increasingly interested in what the virus might mean years after the initial infection has passed. A growing body of research has linked Epstein-Barr virus, or EBV, with multiple sclerosis, a chronic disease in which the immune system attacks the protective covering around nerves. The connection is remarkably strong, although scientists are still investigating exactly how the extremely common virus contributes to a disease that only a small fraction of infected people eventually develop.

The “Kissing Disease” Usually Starts With Epstein-Barr Virus

EBV is one of the world’s most common human viruses and is best known as the leading cause of infectious mononucleosis, which can produce extreme fatigue, fever, sore throat, and swollen lymph nodes. The virus is commonly transmitted through saliva, which explains mono’s famous nickname, although kissing is far from the only way someone can become infected. Many people encounter EBV during childhood and experience few or no noticeable symptoms, while infections occurring during adolescence or young adulthood are more likely to result in recognizable mono.

The Virus Can Stay With You for Life

Unlike an ordinary respiratory infection that is completely cleared from the body, EBV establishes a lifelong infection after someone is exposed. It typically becomes latent inside certain immune cells, meaning the virus remains present without continuously causing the symptoms associated with the original illness. EBV can occasionally reactivate, often without making someone noticeably sick, and researchers are investigating whether this lifelong relationship with the immune system helps explain its connection to conditions that can emerge many years later.

Multiple Sclerosis Affects the Brain and Spinal Cord

Multiple sclerosis, commonly called MS, is a chronic neurological disease in which the immune system mistakenly attacks myelin, the protective material surrounding nerve fibers in the central nervous system. The resulting damage can interfere with communication between the brain and the rest of the body, potentially producing symptoms involving vision, movement, sensation, balance, and fatigue. The severity and progression of MS can vary considerably from person to person, and researchers believe both genetic susceptibility and environmental exposures contribute to who ultimately develops it.

A Huge Study Strengthened the EBV Connection

One of the most influential pieces of evidence came from a Harvard-led study involving more than 10 million active-duty U.S. military personnel whose blood samples had been collected over approximately two decades. Among 801 people who eventually developed MS, researchers found that the risk of the disease increased about 32-fold after infection with EBV. The researchers also found evidence that EBV infection generally occurred before biological signs of MS-related nerve damage appeared, strengthening the argument that the virus may play a role in initiating the disease rather than simply appearing alongside it.

Scientists Have Found a Possible Case of Mistaken Identity

Researchers are also investigating a process known as molecular mimicry as one possible explanation for the relationship. Studies have found that some antibodies produced against an EBV protein called EBNA1 can also recognize proteins found in the brain and central nervous system, potentially causing an immune response originally aimed at the virus to mistakenly target the body’s own tissue. This mechanism remains an active area of research, but it offers scientists a biological explanation for how an infection occurring years earlier might contribute to autoimmune damage later.

Having Mono Does Not Mean You Will Develop MS

The association sounds alarming until one important fact is considered: EBV infects the overwhelming majority of adults, while multiple sclerosis remains comparatively uncommon. That means an EBV infection, including a case of mononucleosis, does not mean someone is destined to develop MS. Researchers increasingly view EBV as an important piece of a much larger puzzle that may also involve genetics, immune-system differences, smoking, vitamin D levels, obesity during adolescence, and other environmental or biological factors.

Researchers Are Asking Whether EBV Could Be Targeted

If EBV contributes directly to the development of MS, preventing or controlling the virus could eventually create entirely new ways to reduce risk. Scientists are studying vaccines designed to prevent EBV infection as well as therapies that might better control the virus once it is already established in the body. No approved EBV vaccine currently exists, and researchers still need clinical trials to determine whether preventing infection would actually reduce future MS cases, but the possibility has made EBV an increasingly important target for neurological research.

The Discovery Could Change How Scientists Think About MS

For decades, researchers have known that MS results from a complicated interaction between a person’s immune system, genetics, and environment, but identifying a specific infectious trigger could reshape how the disease is studied. The accumulating EBV evidence gives scientists a more focused target for investigating why the immune system begins attacking nerve tissue and why that process occurs in only certain people. Future research may determine whether stopping EBV infection, controlling its activity, or interrupting the immune response it triggers can meaningfully reduce MS risk or improve treatment.

The Link Is Important, but It Is Not a Reason to Panic

The relationship between Epstein-Barr virus and multiple sclerosis is one of the most compelling developments in MS research, but it should not turn every past case of mono into a source of fear. EBV is extraordinarily common, whereas only a small proportion of infected people develop MS, showing that the virus alone is not enough to determine someone’s future health. What the research does provide is a promising direction for scientists, with the possibility that understanding an infection many people acquire early in life could eventually help reveal how to prevent or better treat a serious neurological disease decades later.